Danimer Scientific, Inc.
DNMR · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $8,630 | $7,628 | $10,224 | $10,945 |
| % Growth | 13.1% | -25.4% | -6.6% | – |
| Cost of Goods Sold | $15,945 | $14,531 | $18,919 | $19,537 |
| Gross Profit | -$7,315 | -$6,903 | -$8,695 | -$8,592 |
| % Margin | -84.8% | -90.5% | -85% | -78.5% |
| R&D Expenses | $4,580 | $5,109 | $3,311 | $7,575 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6,861 | $6,752 | $6,516 | $17,846 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $65 | $565 | $0 | -$46 |
| Operating Expenses | $11,506 | $12,426 | $9,827 | $25,375 |
| Operating Income | -$18,821 | -$19,329 | -$18,522 | -$31,032 |
| % Margin | -218.1% | -253.4% | -181.2% | -283.5% |
| Other Income/Exp. Net | -$3,016 | -$3,330 | -$8,739 | -$8,400 |
| Pre-Tax Income | -$21,837 | -$22,659 | -$27,261 | -$39,432 |
| Tax Expense | $2 | $2 | $2 | $2 |
| Net Income | -$21,839 | -$22,661 | -$27,263 | -$39,434 |
| % Margin | -253.1% | -297.1% | -266.7% | -360.3% |
| EPS | -0.18 | -0.19 | -0.26 | -0.39 |
| % Growth | 5.3% | 26.9% | 33.3% | – |
| EPS Diluted | -7.2 | -0.19 | -0.26 | -0.39 |
| Weighted Avg Shares Out | 119,713 | 116,465 | 103,968 | 102,145 |
| Weighted Avg Shares Out Dil | 119,713 | 116,465 | 103,968 | 102,145 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $9,631 | $9,072 | $8,838 | $8,509 |
| Depreciation & Amortization | -$65 | $7,438 | $7,531 | $7,372 |
| EBITDA | -$18,821 | -$6,149 | -$10,991 | -$23,460 |
| % Margin | -218.1% | -80.6% | -107.5% | -214.3% |